GR3032539T3 - Derivatives of 1,2,3,4-tetrahydro-9-acridinamine. - Google Patents

Derivatives of 1,2,3,4-tetrahydro-9-acridinamine.

Info

Publication number
GR3032539T3
GR3032539T3 GR20000400235T GR20000400235T GR3032539T3 GR 3032539 T3 GR3032539 T3 GR 3032539T3 GR 20000400235 T GR20000400235 T GR 20000400235T GR 20000400235 T GR20000400235 T GR 20000400235T GR 3032539 T3 GR3032539 T3 GR 3032539T3
Authority
GR
Greece
Prior art keywords
acridinamine
tetrahydro
derivatives
agents
cerebral
Prior art date
Application number
GR20000400235T
Other languages
English (en)
Inventor
Colin Granger
Jeffrey Alan Kester
Walter Hamilton Moos
Anthony Jerome Thomas
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of GR3032539T3 publication Critical patent/GR3032539T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
GR20000400235T 1989-07-31 2000-02-02 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine. GR3032539T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/387,722 US4999430A (en) 1989-07-31 1989-07-31 Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine
EP90114586A EP0411534B1 (en) 1989-07-31 1990-07-30 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine

Publications (1)

Publication Number Publication Date
GR3032539T3 true GR3032539T3 (en) 2000-05-31

Family

ID=23531113

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400235T GR3032539T3 (en) 1989-07-31 2000-02-02 Derivatives of 1,2,3,4-tetrahydro-9-acridinamine.

Country Status (17)

Country Link
US (1) US4999430A (el)
EP (2) EP0411534B1 (el)
JP (1) JP2930245B2 (el)
KR (1) KR910002802A (el)
AT (2) ATE186908T1 (el)
AU (1) AU5994590A (el)
CA (1) CA2022297C (el)
DE (2) DE69017789T2 (el)
DK (2) DK0411534T3 (el)
ES (2) ES2068955T3 (el)
FI (1) FI903752A0 (el)
GR (1) GR3032539T3 (el)
IE (1) IE66823B1 (el)
NO (1) NO903359L (el)
NZ (1) NZ234672A (el)
PT (1) PT94849A (el)
ZA (1) ZA905978B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25124A (en) * 1987-03-17 1991-02-19 Hoechst Roussel Pharma Substituted 9-amino-tetrahydro acridines and related compounds
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
JP2546919B2 (ja) * 1989-11-08 1996-10-23 三菱化学株式会社 ９ーアシルアミノテトラヒドロアクリジン誘導体
US5179100A (en) * 1992-03-09 1993-01-12 Hoechst-Roussel Pharmaceuticals Inc. 4,5-dihydropyrazolo[3,4-a]acridines
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
HU213107B (en) * 1994-02-23 1997-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing acetic acid derivatives and pharmaceutical compositions containing them
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ES2168926B1 (es) * 1999-12-14 2003-10-16 Prous Science S A Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente.
US20080045500A1 (en) * 2004-07-01 2008-02-21 Eisai R&D Management Co., Ltd. Nerve Regeneration Stimulator
CN1315810C (zh) * 2004-08-30 2007-05-16 北京理工大学 哌嗪桥联他克林双体衍生物及其合成方法
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
JP2013513588A (ja) * 2009-12-11 2013-04-22 ジーンコード エーエス Ｇｄｎｆファミリーリガンド（ｇｆｌ）のミメティックまたはｒｅｔシグナル経路活性化因子を用いた、神経系細胞の生存を容易にするための方法
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3889302T2 (de) * 1987-12-03 1994-10-20 Mitsubishi Chem Ind 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.

Also Published As

Publication number Publication date
DE69033369D1 (de) 1999-12-30
NO903359L (no) 1991-02-01
ES2141787T3 (es) 2000-04-01
EP0411534B1 (en) 1995-03-15
JP2930245B2 (ja) 1999-08-03
ES2068955T3 (es) 1995-05-01
ZA905978B (en) 1992-04-29
DE69017789T2 (de) 1995-07-13
EP0411534A2 (en) 1991-02-06
IE66823B1 (en) 1996-02-07
JPH0366670A (ja) 1991-03-22
AU5994590A (en) 1991-01-31
KR910002802A (ko) 1991-02-26
US4999430A (en) 1991-03-12
EP0411534A3 (en) 1991-06-05
DE69017789D1 (de) 1995-04-20
EP0628548A1 (en) 1994-12-14
FI903752A0 (fi) 1990-07-27
DE69033369T2 (de) 2000-05-11
ATE186908T1 (de) 1999-12-15
EP0628548B1 (en) 1999-11-24
DK0411534T3 (da) 1995-07-24
ATE119885T1 (de) 1995-04-15
DK0628548T3 (da) 2000-05-08
NO903359D0 (no) 1990-07-30
CA2022297C (en) 2001-09-18
IE902751A1 (en) 1991-02-27
NZ234672A (en) 1991-11-26
PT94849A (pt) 1991-04-18
CA2022297A1 (en) 1991-02-01

Similar Documents

Publication Publication Date Title
EP0411534A3 (en) Derivatives of 1,2,3,4-tetrahydro-9-acridinamine
IT1229203B (it) Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
ZA906057B (en) 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
IL93161A0 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
GR3006606T3 (el)
AU653802B2 (en) Condensed diazepinones
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
ES2008421A6 (es) Procedimiento para la obtencion de derivados de la pilocarpina.
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
HU904619D0 (en) Process for the production of medicative preparation for treating phlebitis

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees